Dashboard
Manage Tickers

HOOKHOOKIPA Pharma Inc.

Nasdaq www.hookipapharma.com


$ 4.93 $ -0.49 (-9.5 %)    

Monday, 05-Aug-2024 13:42:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 437.97 $ -13.38 (-2.98 %)
DIA $ 386.91 $ -10.32 (-2.6 %)
SPY $ 518.58 $ -15.52 (-2.91 %)
TLT $ 98.76 $ 0.52 (0.53 %)
GLD $ 222.59 $ -2.86 (-1.27 %)
$ 4.67
$ 5.69 x 300
-- x --
-- - --
$ 4.10 - $ 11.30
67,663
na
46.21M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-maintains-market-outperform-on-hookipa-pharma-lowers-price-target-to-23
JMP Securities Maintains Market Outperform...
07/26/2024 18:14:41

JMP Securities analyst Jason Butler maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Market Outperform and lowers the price tar...

hookipa-pharma-announces-director-dr-malte-peters-named-ceo-and-director-terry-coelho-named-executive-vice-president-and-cfo
HOOKIPA Pharma Announces Director Dr. Malt...
07/22/2024 12:36:25

Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Fina...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
07/10/2024 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/09/2024 23:50:03

why-hookipa-pharma-hook-stock-is-volatile-today
Why HOOKIPA Pharma (HOOK) Stock Is Volatil...
07/08/2024 16:17:38

HOOKIPA Pharma shares are trading lower by 10.9% during Monday's session. The company announced a 1-for-10 reverse stock sp...

hookipa-pharma-to-implement-1-for-10-reverse-stock-split-effective-july-9-2024
HOOKIPA Pharma to Implement 1-for-10 Rever...
07/08/2024 11:09:29

HOOKIPA Pharma Inc. (NASDAQ:HOOK, ", HOOKIPA", )))), a company developing a new class of immunotherapeutics based on it...

hookipa-pharma-doses-first-person-in-phase-1b-clinical-trial-of-hb-500-for-treatment-of-hiv
HOOKIPA Pharma Doses First Person In Phase...
07/01/2024 20:32:16

keurig-dr-pepper-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday
Keurig Dr Pepper To Rally Around 18%? Here...
06/05/2024 12:40:48

hc-wainwright--co-maintains-buy-on-hookipa-pharma-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on HOOKI...
06/05/2024 11:39:38

HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and raises the price target from...

hookipa-pharma-announces-phase-2-results-for-hb-200-combined-with-pembrolizumab-in-hpv16-head-and-neck-cancer
HOOKIPA Pharma Announces Phase 2 Results F...
06/04/2024 17:03:31

Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated wi...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/27/2024 16:31:22

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/24/2024 16:31:03

deep-dive-into-hookipa-pharma-stock-analyst-perspectives-4-ratings
Deep Dive Into HOOKIPA Pharma Stock: Analy...
05/21/2024 19:00:30

rbc-capital-reiterates-outperform-on-hookipa-pharma-maintains-5-price-target
RBC Capital Reiterates Outperform on HOOKI...
05/21/2024 17:10:27

RBC Capital analyst Brian Abrahams reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and maintains $5 price target.

hookipa-pharma-q1-2024-gaap-eps-011-beats-010-estimate-sales-36599m-beat-2800m-estimate
HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beat...
05/09/2024 11:15:43

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10...

breaking-down-hookipa-pharma-4-analysts-share-their-views
Breaking Down HOOKIPA Pharma: 4 Analysts S...
04/26/2024 12:00:23

hc-wainwright--co-maintains-buy-on-hookipa-pharma-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on HOOKI...
04/26/2024 10:55:31

HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and lowers the price target from...

hookipa-pharma-announced-its-final-pivotal-phase-23-trial-design-for-hb-200-in-combination-with-pembrolizumab-based-on-alignment-with-the-fda
HOOKIPA Pharma Announced Its Final Pivotal...
04/25/2024 11:24:43

why-is-penny-stock-hookipa-pharma-trading-higher-on-wednesday
Why Is Penny Stock HOOKIPA Pharma Trading ...
04/24/2024 14:31:37

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about ...

hookipa-pharma-shares-are-trading-higher-after-the-company-received-fda-clearance-for-its-ind-application-for-hb-700
HOOKIPA Pharma shares are trading higher a...
04/24/2024 11:51:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)